Live Markets: Healthscope jumps on a new offer

Brambles issued a profit warning this morning, although sales increased by 3% in the first quarter of 2018-19, generating a turnover of 1.4 billion US dollars. Managing Director Graham Chipchase "The business is however facing persistent cost inflation in our major markets, including the United States and Europe." Shares fell 0.4% this morning to $ 10.37, a little more than the 0.05% decline recorded by S & P / ASX200.

"Given the exceptional cost pressures facing our business and the combination of higher offsets and lower costs in the first half of 2017-18, underlying earnings for the first half of 2018-2019 are expected to be broadly in line with the prior period in constant currency. "

The company expects an improvement in earnings in the second half of the current fiscal year, thanks to higher prices and more favorable cost comparisons during the second half of the year. ;Previous exercice.